Phyto Chem (India) Limited (524808) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Phyto Chem (India) Limited ₹32.65, price ₹17.05, upside +91.5%, quality 40 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Phyto Chem (India) Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ₹16.40 – ₹79.25 · fair‑value band ₹27.73 – ₹42.40 · the ₹17.05 price screens below the ₹32.65 fair value. Dashed = 300-day average. As of Sep 24, 2026.
Follow Phyto Chem (India) in your weekly email
Every Wednesday you see whether Phyto Chem (India) is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Phyto Chem (India) Limited manufactures and markets pesticides for agriculture sector in India. The company operates in two segments, Pesticides Formulations and Real Estate Activities. Its products include insecticides, synthetic pyrethroids, fungicides, weedicides, acaricides, plant growth regulators and promotors, and antibiotics.
Show more
Phyto Chem (India) Limited manufactures and markets pesticides for agriculture sector in India. The company operates in two segments, Pesticides Formulations and Real Estate Activities. Its products include insecticides, synthetic pyrethroids, fungicides, weedicides, acaricides, plant growth regulators and promotors, and antibiotics. The company markets its products through dealers and distributors. It is also involved in real estate activities. Phyto Chem (India) Limited was founded in 1989 and is based in Hyderabad, India.
Stock analysis
Phyto Chem (India) Limited (524808) currently trades at ₹17.05, while our model-based Fair Value estimate is ₹32.65, implying the stock looks roughly 47.8% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹41.17 per share, and 6 of the 7 models we run sit above the ₹17.05 price.
Bear case: the Asset-Based group reads lowest at ₹7.12, and 1 of the 7 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹27.73 (bear) to ₹42.40 (bull), the price of ₹17.05 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 40/100 (below-average quality), in the Materials sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Phyto Chem (India) Limited reported revenue of ₹90.7M in FY2026 versus ₹231M in FY2022, a compound −20.9%/yr. Reported net income was −₹18.0M in FY2026.
Key figures
Market cap ₹91.8M (≈ $953K) · P/E ratio 18.1 · P/S ratio 0.17 · EPS (TTM) ₹1.04 · Net margin −19.9% · Return on equity 4.5% · Return on assets (EBIT) −3.4% · Operating margin 4.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 47% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Materials peers we cover trades at −19% fair-value upside, at 92%, 524808 screens cheaper than that median.
Fair Value models
Bear ₹27.73Fair Value ₹32.65Bull ₹42.40
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹0.5305 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.37/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−35.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−30.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−27.2%
Start year 2021 (pandemic). Over 10 years: −8.9% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−9.7%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
4.0% (2021) → −24.3% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+20.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +16.0% a year for the price.
Compare Phyto Chem (India) Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Agrochemicals” was too small, so the broader sector is used.)Materials · 3439 stocks
Beats the sector median on 7/13 measures
A mixed picture versus its sector peers.
Valuation
Quality Score40 · Below median
Fair Value upside+120.0% · Top 25%
Profitability
Return on equity (TTM)4.5% · Above median
Return on assets2.2% · Above median
Net margin (TTM)0.8% · Below median
Operating margin (TTM)4.9% · Below median
Growth and dividend
Revenue growth−15.4% · Bottom 25%
Dividend yield (TTM)0.0% · Bottom 25%
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Materials median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Phyto Chem (India) Limited (524808) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹32.65 versus a price of ₹17.05, about +92% upside (undervalued).
What is the fair value of 524808?
Our model-based fair value for Phyto Chem (India) Limited is ₹32.65 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹17.05.
What is the quality score of 524808?
Phyto Chem (India) Limited has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Phyto Chem (India) Limited (524808)?
Our model-based price target is the fair value of ₹32.65 (as of Sep 24, 2026) from 7 valuation models. Cautious scenario ₹27.73, optimistic scenario ₹42.40. It is a calculation from audited fundamentals, not an analyst target.
What is the Phyto Chem (India) Limited stock forecast for 2026?
Our models put fair value at ₹32.65, about +92% upside versus a price of ₹17.05 (undervalued). Cautious scenario ₹27.73, optimistic scenario ₹42.40. The calculation is refreshed regularly with new filings.
What growth is priced into Phyto Chem (India) Limited (524808)?
For today's price to be fair in a discounted-cash-flow model, Phyto Chem (India) Limited would have to grow free cash flow by +20.8 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -27.2 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 524808 use?
Our models discount Phyto Chem (India) Limited at 10.9 %: a base by market capitalisation (nano), damped by beta 0.49, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Phyto Chem (India) Limited that is +20.8 % per year a year over ten years, using the same discount rate (10.9 %) and the same formula as our fair value.
How much growth has Phyto Chem (India) Limited (524808) delivered so far?
Over the past 5 years revenue at Phyto Chem (India) Limited grew -27.2 % a year. The price currently implies +20.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Phyto Chem (India) Limited (524808) growing?
The median revenue growth in the sector is +8.1 % a year. That is the yardstick for the growth priced into Phyto Chem (India) Limited (+20.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Phyto Chem (India) Limited (524808)?
The free-cash-flow yield on the price is 12.19 %: that much free cash flow Phyto Chem (India) Limited produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Phyto Chem (India) Limited (524808)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Phyto Chem (India) Limited it is ₹32.65 per share (as of Sep 24, 2026), against a price of ₹17.05. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Phyto Chem (India) Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 524808 trades below its calculated fair value: price ₹17.05, fair value ₹32.65, a gap of about +92% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 524808?
No. The price is what the market pays today (₹17.05); the fair value is what the company's own numbers justify (₹32.65). For Phyto Chem (India) Limited the two are ₹15.60 per share apart. That gap is exactly why we show both numbers side by side.
How much is Phyto Chem (India) Limited worth?
The market values Phyto Chem (India) Limited at about ₹91.8M (market capitalisation, as of Sep 24, 2026). Per share that is ₹17.05; our models calculate a fair value of ₹32.65 per share.
What do the bullish and bearish scenarios say about 524808?
Our models span a range for Phyto Chem (India) Limited: cautious scenario ₹27.73, base ₹32.65, optimistic ₹42.40 per share (as of Sep 24, 2026, price ₹17.05). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 524808?
Phyto Chem (India) Limited trades at a price-to-earnings ratio of 18.1 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹32.65 is built from several models across several years. Other multiples: P/B 2.0, P/S 0.2.
How solid is the balance sheet of Phyto Chem (India) Limited (524808)?
Balance-sheet figures for Phyto Chem (India) Limited (as of Sep 24, 2026): return on equity 4.5%, debt of 0.02 per unit of equity. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is 524808 from its 52-week high?
Phyto Chem (India) Limited trades at ₹17.05, about 47% below its 52-week high of ₹32.28 and 4% above the low of ₹16.40 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹32.65 is for.
Which stocks are comparable to Phyto Chem (India) Limited?
From the same area (Materials) we also value NAGTECH, PHYTO, AKTR, DAIOS, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Phyto Chem (India) Limited stock attractive at the current price?
The data as of Sep 24, 2026: price ₹17.05, calculated fair value ₹32.65 (+92%), Quality Score 40/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 524808 calculated?
We run Phyto Chem (India) Limited through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹32.65, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Phyto Chem (India) Limited currently trades 48 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Phyto Chem (India) Limited (524808)?
The closing price on Oct 1, 2026 was ₹17.05. Our model-based fair value is ₹32.65, about +92% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Phyto Chem (India) Limited right now?
The large discount to fair value meets weak quality (40/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (₹27.73). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Phyto Chem (India) Limited
How large is the market capitalisation of Phyto Chem (India) Limited (524808)?
The market capitalisation of Phyto Chem (India) Limited is ₹91.8M (≈ $953K). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Phyto Chem (India) Limited (524808)?
The price-to-sales ratio of Phyto Chem (India) Limited is 0.17 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Phyto Chem (India) Limited (524808)?
Earnings per share at Phyto Chem (India) Limited are ₹1.04 (price ÷ EPS = P/E 18.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Phyto Chem (India) Limited (524808)?
The net margin of Phyto Chem (India) Limited is −19.9% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Phyto Chem (India) Limited (524808)?
The return on equity (ROE) of Phyto Chem (India) Limited is 4.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Phyto Chem (India) Limited (524808)?
On an EBIT basis the return on assets of Phyto Chem (India) Limited is −3.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Phyto Chem (India) Limited (524808)?
The operating margin of Phyto Chem (India) Limited is 4.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Phyto Chem (India) Limited (524808)?
Revenue at Phyto Chem (India) Limited is growing −15.4% versus a year earlier (3y avg −30.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Phyto Chem (India) Limited (524808)?
Earnings per share at Phyto Chem (India) Limited are growing −19.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Phyto Chem (India) Limited (524808) carry?
The net debt of Phyto Chem (India) Limited is ₹205M (fiscal year 2026, ≈ 22.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Phyto Chem (India) Limited in the live analysis
One click puts Phyto Chem (India) Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
